Nanoparticles crossing blood-brain barrier need specific design for normal, neurodegenerative or cancerous brain conditions

By sjmartinez • August 8, 2024

Ljubimova JY, Holler E, Black KL, Ljubimov AV. Nanoparticles crossing blood-brain barrier need specific design for normal, neurodegenerative or cancerous brain conditions. Nanomedicine (Lond). 2024 Aug 7:1-4. doi: 10.1080/17435889.2024.2380241. Epub ahead of print. PMID: 39109486.

Tags: Alzheimer's and tumor, BBB, blood brain barrier (BBB), Blood-brain-barrier, Cedars Sinai DoM, cell-specific drug delivery, central nervous system, CNS immunity, diabetic retinopathy, Endocrinology, multifunctional nanoparticles, normal, peptides, Publications

Disparities in Health Care Seeking and Physician Diagnosis of Irritable Bowel Syndrome: Results From a United States Survey

Almario CV, Liu J, Higgins C, Yerneni N, Boules M, Chey WD, Chang L. Disparities in Health Care Seeking and Physician Diagnosis of Irritable Bowel[...]

Longitudinal Study on the Influence of Physical Activity in Managing Fatigue in Patients With Colorectal Cancer

Liu L, Kazemian E, Loroña NC, Shirazipour C, Gong J, Crowder SL, Nguyen N, Damerell V, Mooney K, Playdon MC, Ulrich CM, Li CI, Shibata[...]

Artificial intelligence-derived splenic response in cardiac positron emission tomography is associated with major adverse cardiovascular events: a multi-site study

Ramirez G, Dharmavaram NL, Shanbhag A, Miller RJH, Kavanagh PB, Yi J, Lemley M, Builoff V, Marcinkiewicz A, Dey D, Hainer J, Wopperer S, Knight[...]